• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Failure mode and effect analysis in human islet isolation: from the theoretical to the practical risk.人胰岛分离中的失效模式和影响分析:从理论到实际风险。
Islets. 2021 Mar 4;13(1-2):1-9. doi: 10.1080/19382014.2020.1856618. Epub 2021 Feb 22.
2
Failure mode and effect analysis applied to improve the medication management process in a pharmacy of a teaching hospital and a proposal for a simplified rating system.失效模式与效应分析在教学医院药剂科用药管理流程改进中的应用及简化评分系统的建议
Eur J Hosp Pharm. 2023 Mar;30(e1):e55-e60. doi: 10.1136/ejhpharm-2021-003013. Epub 2022 Jan 21.
3
Comprehensive protocol of traceability during IVF: the result of a multicentre failure mode and effect analysis.IVF 过程中可追溯性的综合方案:多中心失效模式和影响分析的结果。
Hum Reprod. 2017 Aug 1;32(8):1612-1620. doi: 10.1093/humrep/dex144.
4
How can the failure mode and effect analysis improve the working processes in the ART center?失效模式与效应分析如何改进 ART 中心的工作流程?
Eur J Obstet Gynecol Reprod Biol. 2024 Nov;302:43-55. doi: 10.1016/j.ejogrb.2024.08.041. Epub 2024 Aug 28.
5
Evaluation and improvement the safety of total marrow irradiation with helical tomotherapy using repeat failure mode and effects analysis.运用失效模式与影响分析对螺旋断层放疗全骨髓照射的安全性进行评估和改进。
Radiat Oncol. 2019 Dec 27;14(1):238. doi: 10.1186/s13014-019-1433-7.
6
Failure mode and effects analysis: a comparison of two common risk prioritisation methods.失效模式与效应分析:两种常见风险优先级排序方法的比较
BMJ Qual Saf. 2016 May;25(5):329-36. doi: 10.1136/bmjqs-2015-004130. Epub 2015 Jul 13.
7
A failure modes and effects analysis study for gynecologic high-dose-rate brachytherapy.一项针对妇科高剂量率近距离放射治疗的失效模式与效应分析研究。
Brachytherapy. 2015 Nov-Dec;14(6):866-75. doi: 10.1016/j.brachy.2015.06.007. Epub 2015 Jul 21.
8
A comparison of two prospective risk analysis methods: Traditional FMEA and a modified healthcare FMEA.两种前瞻性风险分析方法的比较:传统失效模式与效应分析(FMEA)和改良的医疗保健FMEA
Med Phys. 2016 Dec;43(12):6347. doi: 10.1118/1.4966129.
9
Failure mode and effects analysis: A community practice perspective.失效模式与效应分析:社区实践视角
J Appl Clin Med Phys. 2017 Nov;18(6):258-267. doi: 10.1002/acm2.12190. Epub 2017 Sep 25.
10
A risk assessment of automated treatment planning and recommendations for clinical deployment.自动化治疗计划的风险评估及临床应用建议。
Med Phys. 2019 Jun;46(6):2567-2574. doi: 10.1002/mp.13552. Epub 2019 May 6.

引用本文的文献

1
Comprehensive biocompatibility profiling of human pancreas-derived biomaterial.人胰腺来源生物材料的综合生物相容性分析
Front Bioeng Biotechnol. 2025 Apr 25;13:1518665. doi: 10.3389/fbioe.2025.1518665. eCollection 2025.
2
Long-term safety of photobiomodulation exposure to beta cell line and rat islets in vitro and in vivo.体外和体内光生物调节暴露对β细胞系和大鼠胰岛的长期安全性。
Sci Rep. 2024 Nov 6;14(1):26874. doi: 10.1038/s41598-024-77660-8.
3
Analysis on the application of FMEA in 'instrument and equipment surface cleaning and disinfection' in hospitals based on standardization and cleaning and disinfection information system management.基于标准化和清洗消毒信息系统管理,分析 FMEA 在医院“仪器设备表面清洗消毒”中的应用。
Front Public Health. 2024 Sep 25;12:1444721. doi: 10.3389/fpubh.2024.1444721. eCollection 2024.

本文引用的文献

1
Heterogeneity of Human Pancreatic Islet Isolation Around Europe: Results of a Survey Study.欧洲人类胰腺胰岛分离的异质性:一项调查研究的结果。
Transplantation. 2020 Jan;104(1):190-196. doi: 10.1097/TP.0000000000002777.
2
Validation of a New North American Islet Donor Score for Donor Pancreas Selection and Successful Islet Isolation in a Medium-Volume Islet Transplant Center.一种新的北美胰岛供者评分在中量胰岛移植中心用于供体胰腺选择和成功胰岛分离的验证。
Cell Transplant. 2019 Feb;28(2):185-194. doi: 10.1177/0963689718816989. Epub 2018 Dec 6.
3
Comparison of Clostripain and Neutral Protease as Supplementary Enzymes for Human Islet Isolation.比较 Clostripain 和中性蛋白酶作为人胰岛分离的补充酶。
Cell Transplant. 2019 Feb;28(2):176-184. doi: 10.1177/0963689718811614. Epub 2018 Nov 13.
4
Pancreas preservation fluid microbial contamination is associated with poor islet isolation outcomes - a multi-centre cohort study.胰腺保存液微生物污染与胰岛分离效果不佳相关——一项多中心队列研究。
Transpl Int. 2018 Aug;31(8):917-929. doi: 10.1111/tri.13159. Epub 2018 Apr 16.
5
Methods of Human Islet Culture for Transplantation.用于移植的人胰岛培养方法。
Cell Transplant. 2004 Sep;13(6):605-618. doi: 10.3727/000000004783983602.
6
Enzyme Development for Human Islet Isolation: Five Decades of Progress or Stagnation?用于人类胰岛分离的酶的发展:五十年的进步还是停滞?
Rev Diabet Stud. 2017 Spring;14(1):22-38. doi: 10.1900/RDS.2017.14.22. Epub 2017 Jun 12.
7
Clinical pancreatic islet transplantation.临床胰腺胰岛移植。
Nat Rev Endocrinol. 2017 May;13(5):268-277. doi: 10.1038/nrendo.2016.178. Epub 2016 Nov 11.
8
Effect of Manufacturing Procedures on Human Islet Isolation From Donor Pancreata Standardized by the North American Islet Donor Score.北美胰岛供体评分标准化下制造程序对从供体胰腺中分离人胰岛的影响。
Cell Transplant. 2017 Jan 24;26(1):33-44. doi: 10.3727/096368916X692834. Epub 2016 Aug 12.
9
National Institutes of Health-Sponsored Clinical Islet Transplantation Consortium Phase 3 Trial: Manufacture of a Complex Cellular Product at Eight Processing Facilities.美国国立卫生研究院资助的临床胰岛移植联盟3期试验:在八个处理设施中生产复杂细胞产品。
Diabetes. 2016 Nov;65(11):3418-3428. doi: 10.2337/db16-0234. Epub 2016 Jul 27.
10
Effect of the Implementation of Barcode Technology and an Electronic Medication Administration Record on Adverse Drug Events.条形码技术和电子给药记录的实施对药物不良事件的影响。
Hosp Pharm. 2016 Jun;51(6):474-83. doi: 10.1310/hpj5106-474.

人胰岛分离中的失效模式和影响分析:从理论到实际风险。

Failure mode and effect analysis in human islet isolation: from the theoretical to the practical risk.

机构信息

Cell Isolation and Transplantation Center, Department of Surgery, Geneva University Hospital, Geneva, Switzerland.

Clinical Pharmacy Department , Grenoble Alpes University, Grenoble, France.

出版信息

Islets. 2021 Mar 4;13(1-2):1-9. doi: 10.1080/19382014.2020.1856618. Epub 2021 Feb 22.

DOI:10.1080/19382014.2020.1856618
PMID:33616002
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8018422/
Abstract

This study aimed to assess the global mapping risk of human islet isolation, using a failure mode and effect analysis (FMEA), and highlight the impact of quality assurance procedures on the risk level of criticality. Risks were scored using the risk priority number (RPN) scoring method. The risk level of criticality was made based on RPN and led to risk classification (low to critical). A raw risk analysis and a risk control analysis (with control means and quality assurance performance) were undertaken. The process of human islet isolation was divided into 11 steps, and 230 risks were identified. Analysis of the highest RPN of each of the 11 steps showed that the 4 highest risks were related to the pancreas digestion and islet purification stages. After implementation of reduction measures and controls, critical and severe risks were reduced by 3-fold and by 2-fold, respectively, so that 90% of risks could be considered as low to moderate. FMEA has proven to be a powerful approach for the identification of weaknesses in the islet isolation processes. The results demonstrated the importance of staff qualification and continuous training and supported the contribution of the quality assurance system to risk reduction.

摘要

本研究旨在通过失效模式与影响分析(FMEA)评估全球人类胰岛分离的风险图谱,并强调质量保证程序对关键风险水平的影响。使用风险优先数(RPN)评分方法对风险进行评分。基于 RPN 确定风险的关键性水平,从而进行风险分类(低危至高危)。进行了原始风险分析和风险控制分析(包括控制手段和质量保证绩效)。将人类胰岛分离过程分为 11 个步骤,共确定了 230 个风险。对每个步骤的最高 RPN 进行分析表明,前 4 大风险与胰腺消化和胰岛纯化阶段有关。实施降低措施和控制措施后,关键和严重风险分别降低了 3 倍和 2 倍,因此 90%的风险可被视为低至中度。FMEA 已被证明是识别胰岛分离过程弱点的有力方法。研究结果表明,工作人员资质和持续培训的重要性,以及质量保证体系对降低风险的贡献。